65 -- Purchase of Fetal Bovine Serum

The Centers for Disease Control and Prevention plans to issue a sole source purchase order to Atlas Biologicals, Inc. for 200 bottles of 500ml Fetal Bovine Serum F-0500-A. This specific serum is essential as it matches the batch lots used in prior CDC testing, ensuring continuity and validity of previous test results. A critical stipulation for this purchase is that the serum must be 100 percent of U.S. origin, meaning it must come exclusively from animals processed within the United States. The CDC has determined that only Atlas Biologicals meets this unique requirement, justifying the sole source procurement under federal acquisition regulations FAR 6.302-1 and 6.302-2. Consequently, no solicitation is being issued, although interested parties may express their capability to meet this need. This contract is not set aside for small businesses and is handled through direct procurement given the unique nature of the product and source. The purchased serum will support CDC testing protocols where product consistency and origin are crucial. Linda M. Young serves as the point of contact for contractual inquiries, and the NAICS code associated with this procurement is 325413. The sole source determination emphasizes the importance of product uniformity in continued testing efforts and CDC’s reliance on Atlas Biologicals as the only responsible supplier.